Clinical Trials Browser

Small Cell Lung Carcinoma

Advanced Solid Tumour

Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumour

Ovarian Neoplasms

Advanced Solid Tumour

Advanced Solid Tumor

Diffuse Intrinsic Pontine Glioma

Advanced Breast Cancer

Advanced Malignant Tumors

Squamous Cell Carcinoma of Head and Neck

Advanced Solid Tumour

Advanced Solid Tumor

Advanced Solid Tumors

Carcinoma, Non-Small-Cell Lung

Advanced Gynecological Malignancies

Advanced Solid Tumors

Non-small Lung Cancer

Unresectable Locally Recurrent Breast Cancer

Digestive System Neoplasms

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Metastatic Solid Tumors

Small Cell Lung Carcinoma

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Multiple Myeloma

Advanced Lung Cancer

Leukemia, Myeloid, Acute

Advanced Solid Tumor

Extensive Stage Small Cell Lung Cancer

Gastroenteropancreatic Neuroendocrine Tumors

Triple Negative Breast Neoplasms

Ovarian Neoplasms

Advance Solid Tumors

Solid Tumors

Multiple Myeloma

Triple Negative Breast Neoplasms

Advanced Lung Carcinoma

Advanced Solid Tumors

Advanced Malignant Solid Tumor

Advanced Solid Tumors

Advanced Malignant Solid Tumor

mCRPC (Metastatic Castration-resistant Prostate Cancer)

Advanced Solid Tumors Cancer

Biliary Tract Neoplasms

Uterine Cervical Neoplasms

Advanced Solid Tumor

Clinical Trials

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

SKB410 for Injection in Solid Tumors

A Phase II Study of SKB571 in Patients With Lung Cancer

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer

A Study of SKB571 in Participants With Gastrointestinal Tumors

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

A Study of SKB315 in Patients With Advanced Solid Tumors

A Study of SKB518 in Patients With Advanced Solid Tumors

SKB445 for Injection in Solid Tumors

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

SKB500 Combinations in Patients With Small Cell Lung Cancer

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

MAGNETISMM-5

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Study of ZG005 in Patients With Advanced Solid Tumors

Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

A Study of SHR-A1811 in Subjects With Ovarian Cancer

A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

A Clinical Study of SHR-9539 in Patients With Multiple Myeloma

A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care

A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

A Study of MHB009C in Patients With Advanced Solid Tumors

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

A Study of MHB042C in Patients With Advanced Solid Tumors

A Study of MHB048C in Patients With Advanced Solid Tumors

First-In-Human Study of KHN922 for Injection

A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors